Literature DB >> 5454324

Treatment of hypertension with clonidine.

A I MacDougall, G J Addis, N MacKay, I W Dymock, A G Turpie, D L Ballingall, W J MacLennan, B Whiting, J G MacArthur.   

Abstract

Clonidine, in a daily dosage of 0.15-4.8 mg., effectively lowered systolic and diastolic pressures in 26 out of 28 impatients with moderate to severe hypertension, including five with primary renal disease. The action of the drug did not depend on posture and was not associated with reduction in renal function. Side-effects were not severe, but mental changes occurred in four patients.Clonidine is a useful alternative to currently available antihypertensive drugs, but further evaluation of its longterm efficacy is required.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5454324      PMCID: PMC1701398          DOI: 10.1136/bmj.3.5720.440

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  13 in total

1.  Pharmacodynamic effects of a new antihypertensive drug, Catapres (ST-155).

Authors:  G Onesti; A B Schwartz; K E Kim; C Swartz; A N Brest
Journal:  Circulation       Date:  1969-02       Impact factor: 29.690

2.  The antihypertensive effects of an imidazoline compound.

Authors:  M Davidov; N Kakaviatos; F A Finnerty
Journal:  Clin Pharmacol Ther       Date:  1967 Nov-Dec       Impact factor: 6.875

3.  Clinical observations on a new antihypertensive drug, 2-(2,6-dichlorphenylamine)-2-imidazoline hydrochloride.

Authors:  G Smet; S W Hoobler; S Sanbar; S Julis
Journal:  Am Heart J       Date:  1969-04       Impact factor: 4.749

4.  [First observations on an antihypertensive effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride in man].

Authors:  D Michel; W Zimmermann; A Nassehi; P Seraphim
Journal:  Dtsch Med Wochenschr       Date:  1966-09-02       Impact factor: 0.628

5.  [Therapeutic examination and studies on renal function with a new antihypertensive agent (St 155)].

Authors:  H Frank; K von Loewenich-Lagois
Journal:  Dtsch Med Wochenschr       Date:  1966-09-23       Impact factor: 0.628

6.  [Critical considerations on the method of action of 2-(2,6-dichlorophenylamino)-2-imidazoline-hydrochloride].

Authors:  W Graubner; M Wolf
Journal:  Arzneimittelforschung       Date:  1966-08

7.  [Clinical and experimental study with the new blood pressure depressant 2-(2,6-dichlorphenylamino)-2-imidazole-hydrochloride].

Authors:  G Grabner; P Michalek; D Pokorny; E Vormittag
Journal:  Arzneimittelforschung       Date:  1966-09

8.  [Clinical experiences with a new antihypertensive agent].

Authors:  W Lieb; K Ridders
Journal:  Arzneimittelforschung       Date:  1966-12

9.  [The effect of an imidazole derivative on arterial blood pressure, hemodynamics and ventilation].

Authors:  K Kochsiek; H Fritsche
Journal:  Arzneimittelforschung       Date:  1966-09

10.  [Clinical and clinical-experimental studies with a new blood pressure lowering substance: dichlorophenylaminoimidazoline].

Authors:  K D Bock; V Heimsoth; P Merguet; J Schönermark
Journal:  Dtsch Med Wochenschr       Date:  1966-10-07       Impact factor: 0.628

View more
  6 in total

1.  Treatment of severe hypertension and hypertensive emergencies with intravenous clonidine hydrochloride.

Authors:  A P Niarchos; A K Baksi
Journal:  Postgrad Med J       Date:  1973-12       Impact factor: 2.401

Review 2.  Drug-induced psychiatric disorders and their management.

Authors:  L E Hollister
Journal:  Med Toxicol       Date:  1986 Nov-Dec

3.  A comparative trial of clonidine, propranolol and placebo in the treatment of moderate hypertension.

Authors:  P R Wilkinson; E B Raftery
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

Review 4.  Is Mania the Hypertension of the Mood? Discussion of A Hypothesis.

Authors:  Zoltán Rihmer; Xénia Gonda; Péter Döme
Journal:  Curr Neuropharmacol       Date:  2017-04       Impact factor: 7.363

5.  Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans.

Authors:  E R Samuels; E Szabadi
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

Review 6.  Current and Emerging Classes of Pharmacological Agents for the Management of Hypertension.

Authors:  Utkarsh Ojha; Sanjay Ruddaraju; Navukkarasu Sabapathy; Varun Ravindran; Pitchaya Worapongsatitaya; Jeesanul Haq; Raihan Mohammed; Vinod Patel
Journal:  Am J Cardiovasc Drugs       Date:  2021-12-08       Impact factor: 3.283

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.